Slovakian experience with continuous infusion of factor VIII for surgery in hemophilia A and von Willebrand disease

被引：0

作者：

Batorova, A

Filova, A

Pappova, K

Martinowitz, U

机构：

[1] UNIV HOSP, NATL HEMOPHILIA CTR, INST HEMATOL, BRATISLAVA, SLOVAKIA

[2] CHAIM SHEBA MED CTR, NATL HEMOPHILIA CTR, IL-52621 TEL HASHOMER, ISRAEL

来源：

THROMBOSIS AND HAEMOSTASIS | 1997年

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：PS227 / PS227

页数：1

共 50 条

[31] PHARMACOKINETIC MODELING OF THE VON WILLEBRAND FACTOR - FACTOR VIII INTERACTION IN PERIOPERATIVE VON WILLEBRAND DISEASE PATIENTS [J].

Bukkems, L. H. ;

Heijdra, J. ;

de Jager, N. ;

Hazendonk, H. ;

Fijnvandraat, K. ;

Meijer, K. ;

Eikenboom, J. ;

Laros-van Gorkom, B. ;

Leebeek, F. ;

Cnossen, M. ;

Mathot, R. .

HAEMOPHILIA, 2021, 27 :147-147

[32] Population pharmacokinetics of the von Willebrand factor-factor VIII interaction in patients with von Willebrand disease [J].

Bukkems, Laura H. ;

Heijdra, Jessica M. ;

de Jager, Nico C. B. ;

Hazendonk, Hendrika C. A. M. ;

Fijnvandraat, Karin ;

Meijer, Karina ;

Eikenboom, Jeroen C. J. ;

Laros-van Gorkom, Britta A. P. ;

Leebeek, Frank W. G. ;

Cnossen, Marjon H. ;

Mathot, Ron A. A. .

BLOOD ADVANCES, 2021, 5 (05) :1513-1522

[33] von Willebrand factor/factor VIII concentrate (Wilate) prophylaxis in children and adults with von Willebrand disease [J].

Sidonio Jr, Robert F. ;

Boban, Ana ;

Dubey, Leonid ;

Inati, Adlette ;

Kiss, Csongor ;

Boda, Zoltan ;

Lissitchkov, Toshko ;

Nemes, Laszlo ;

Novik, Dzmitry ;

Peteva, Elina ;

Taher, Ali T. ;

Timofeeva, Margarita Arkadevna ;

Vilchevska, Kateryna V. ;

Vdovin, Vladimir ;

Werner, Sylvia ;

Knaub, Sigurd ;

Khayat, Claudia Djambas .

BLOOD ADVANCES, 2024, 8 (06) :1405-1414

[34] Interaction of factor VIII and von Willebrand factor and the identification of type 2 N von Willebrand disease [J].

Favaloro, Emmanuel J. .

THROMBOSIS RESEARCH, 2011, 127 (01) :2-3

[35] Co-expression of von Willebrand factor with factor VIII in epidermis augments circulating factor VIII in hemophilia a mice [J].

Goldbeck, AL ;

Kobayashi, S ;

Lu, H ;

Sankar, R ;

Fakharzadeh, SS .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (01) :264-264

[36] Pharmacokinetic evaluation before surgery of two patients affected by von Willebrand disease and treated with von Willebrand factor/factor VIII concentrate Wilate® [J].

Preti, P. S. ;

Bertolino, G. ;

Spataro, C. ;

Ciola, M. ;

Ambaglio, C. .

HAEMOPHILIA, 2019, 25 :153-153

[37] CONTINUOUS INFUSION THERAPY OF FACTOR-VIII CONCENTRATE IN HEMOPHILIA-A [J].

LEVIN, J ;

NESS, PM ;

BELL, WR .

TRANSFUSION, 1981, 21 (05) :621-622

[38] Dynamics of plasma factor VIII during the continuous infusion of factor VIII concentrates in twenty patients with hemophilia A [J].

Nishiya, K. ;

Nogami, K. ;

Tanaka, I ;

Shibata, M. ;

Ogiwara, K. ;

Matsumoto, T. ;

Shima, M. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 :929-930

[39] Experience with Optivate®, a new high purity concentrate of factor VIII with von Willebrand factor, in patients undergoing surgery [J].

Hay, C. R. M. ;

Hellmann, A. ;

Dmoszynska, A. ;

Baglin, T. ;

O'Shaunessey, D. ;

Makris, M. ;

Shaikh-Zaidi, R. ;

Dash, C. H. .

HAEMOPHILIA, 2011, 17 (03) :428-432

[40] MULTIMERIC STRUCTURE OF FACTOR-VIII-VON WILLEBRAND FACTOR IN VON WILLEBRANDS DISEASE [J].

MEYER, D ;

OBERT, B ;

PIETU, G ;

LAVERGNE, JM ;

ZIMMERMAN, TS .

JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1980, 95 (04) :590-602

← 1 2 3 4 5 →